The NHS will start prescribing the weight loss jab Mounjaro (tirzepatide) to around 220,000 severely obese patients with health issues, marking a significant rollout for GPs in England. While the drug, which aids weight management and blood sugar control, offers potential benefits, doctors express concerns about the additional workload and emphasize the need for a comprehensive approach to obesity that includes lifestyle changes.
